L.I.A. Pure Capital holds 3,057,488 Evogene ordinary shares, equal to 19.35% of the class, in an activist position. The stake matters to investors because L.I.A. Pure Capital and Invest Pro are urging shareholders to support their nominees for Evogene’s board while citing performance, governance and board composition.

Key Highlights

  • L.I.A. Pure Capital reports beneficial ownership of 3,057,488 Evogene ordinary shares, or 19.35% of the class.
  • L.I.A. Pure Capital and Invest Pro responded to Evogene’s August 25, 2026 press release with a Shareholder communication.
  • The reporting persons encouraged shareholders to support their nominees at Evogene’s upcoming annual meeting.

L.I.A. Pure Capital holds 3,057,488 ordinary shares of Evogene Ltd. (NASDAQ: EVGN), representing 19.35% of the class. The position is identified as activist under a Schedule 13D. L.I.A. Pure Capital and Invest Pro Shukai Hon Ltd. expressed views regarding Evogene’s performance, governance and board composition. They are also encouraging shareholders to support their nominees for election to Evogene’s Board of Directors at the upcoming annual meeting.

Ownership Basis Set

The securities are ordinary shares with a Par Value of NIS 0.20 per share. Evogene’s American Depositary Shares each represent one ordinary share. The reported securities are held by L.I.A. Pure Capital.

Invest Pro Position

Invest Pro Shukai Hon Ltd. is also listed with beneficial ownership of 3,057,488 shares, equal to 19.35% of Evogene’s ordinary shares. The communication was disseminated on August 28, 2026, in response to Evogene’s August 25, 2026 press release. Kfir Silberman signed for L.I.A. Pure Capital, and Ron Yair Peled signed for himself.

Board Nominee Campaign

The investors’ stated purpose includes expressing views on Evogene’s performance, governance and board composition. Their communication urged shareholders to back the reporting persons’ nominees in the board election at the upcoming annual meeting.

Peers Moving on This News